ABSTRACT
Touch sensation is primarily encoded by mechanoreceptors, called low-threshold mechanoreceptors (LTMRs), with their cell bodies in the dorsal root ganglia. Because of their great diversity in terms of molecular signature, terminal endings morphology, and electrophysiological properties, mirroring the complexity of tactile experience, LTMRs are a model of choice to study the molecular cues differentially controlling neuronal diversification. While the transcriptional codes that define different LTMR subtypes have been extensively studied, the molecular players that participate in their late maturation and in particular in the striking diversity of their end-organ morphological specialization are largely unknown. Here we identified the TALE homeodomain transcription factor Meis2 as a key regulator of LTMRs target-field innervation in mice. Meis2 is specifically expressed in cutaneous LTMRs, and its expression depends on target-derived signals. While LTMRs lacking Meis2 survived and are normally specified, their end-organ innervations, electrophysiological properties, and transcriptome are differentially and markedly affected, resulting in impaired sensory-evoked behavioral responses. These data establish Meis2 as a major transcriptional regulator controlling the orderly formation of sensory neurons innervating peripheral end organs required for light touch.
Subject(s)
Homeodomain Proteins , Nervous System Physiological Phenomena , Transcription Factors , Animals , Mice , Gene Expression Regulation , Mechanoreceptors , Sensory Receptor Cells , Transcription Factors/genetics , Homeodomain Proteins/geneticsABSTRACT
Flying insects have invaded all the aerial space on Earth and this astonishing radiation could not have been possible without a remarkable morphological diversification of their flight appendages. Here, we show that characteristic spatial expression profiles and levels of the Hox genes Antennapedia (Antp) and Ultrabithorax (Ubx) underlie the formation of two different flight organs in the fruit fly Drosophila melanogaster. We further demonstrate that flight appendage morphology is dependent on specific Hox doses. Interestingly, we find that wing morphology from evolutionary distant four-winged insect species is also associated with a differential expression of Antp and Ubx. We propose that variation in the spatial expression profile and dosage of Hox proteins is a major determinant of flight appendage diversification in Drosophila and possibly in other insect species during evolution.
Subject(s)
Antennapedia Homeodomain Protein/genetics , Drosophila Proteins/genetics , Flight, Animal , Homeodomain Proteins/genetics , Transcription Factors/genetics , Animals , Antennapedia Homeodomain Protein/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/anatomy & histology , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , Gene Dosage , Gene Expression Profiling/methods , Gene Expression Regulation , Homeodomain Proteins/metabolism , Transcription Factors/metabolism , Wings, Animal/anatomy & histology , Wings, Animal/metabolismABSTRACT
Peripheral neuropathic pain (PNP) is a debilitating and intractable chronic disease, for which sensitization of somatosensory neurons present in dorsal root ganglia that project to the dorsal spinal cord is a key physiopathological process. Here, we show that hematopoietic cells present at the nerve injury site express the cytokine FL, the ligand of fms-like tyrosine kinase 3 receptor (FLT3). FLT3 activation by intra-sciatic nerve injection of FL is sufficient to produce pain hypersensitivity, activate PNP-associated gene expression and generate short-term and long-term sensitization of sensory neurons. Nerve injury-induced PNP symptoms and associated-molecular changes were strongly altered in Flt3-deficient mice or reversed after neuronal FLT3 downregulation in wild-type mice. A first-in-class FLT3 negative allosteric modulator, discovered by structure-based in silico screening, strongly reduced nerve injury-induced sensory hypersensitivity, but had no effect on nociception in non-injured animals. Collectively, our data suggest a new and specific therapeutic approach for PNP.
Subject(s)
Peripheral Nervous System Diseases/metabolism , fms-Like Tyrosine Kinase 3/metabolism , Animals , Blotting, Western , Cells, Cultured , Ganglia, Spinal/metabolism , Immunohistochemistry , In Situ Hybridization , Mice , Mice, Inbred C57BL , Neuralgia/genetics , Neuralgia/metabolism , Peripheral Nervous System Diseases/genetics , RNA, Small Interfering/genetics , Real-Time Polymerase Chain Reaction , Sensory Receptor Cells/metabolism , fms-Like Tyrosine Kinase 3/geneticsABSTRACT
Restless Legs Syndrome (RLS) is a genetically complex neurological disorder in which overlapping genetic risk factors may contribute to the diversity and heterogeneity of the symptoms. The main goal of the study was to investigate, through analysis of heart rate variability (HRV), whether in RLS patients the MEIS1 polymorphism at risk influences the sympathovagal regulation in different sleep stages. Sixty-four RLS patients with periodic leg movement index above 15 per hour, and 38 controls underwent one night of video-polysomnographic recording. HRV in the frequency- and time- domains was analyzed during nighttime sleep. All RLS patients were genotyped, and homozygotes for rs2300478 in the MEIS1 locus were used for further analysis. Comparison of the sympathovagal pattern of RLS patients to control subjects did not show significant differences after adjustments for confounding factors in frequency-domain analyses, but showed an increased variability during N2 and N3 stages in time-domain analyses in RLS patients. Sorting of RLS patients according to MEIS1 polymorphism reconfirmed the association between MEIS1 and PLMS, and showed a significant increased sympathovagal balance during N3 stage in those homozygotes for the risk allele. RLS patients should be considered differently depending on MEIS1 genotype, some being potentially at risk for cardiovascular disorders.
Subject(s)
Myeloid Ecotropic Viral Integration Site 1 Protein/genetics , Polymorphism, Single Nucleotide , Restless Legs Syndrome/genetics , Restless Legs Syndrome/physiopathology , Sympathetic Nervous System/physiopathology , Vagus Nerve/physiopathology , Adult , Aged , Female , Genotype , Heart Rate/physiology , Humans , Leg/physiopathology , Male , Middle Aged , Movement , Polysomnography , Sleep Stages/physiologyABSTRACT
Although cardio-vascular incidents and sudden cardiac death (SCD) are among the leading causes of premature death in the general population, the origins remain unidentified in many cases. Genome-wide association studies have identified Meis1 as a risk factor for SCD. We report that Meis1 inactivation in the mouse neural crest leads to an altered sympatho-vagal regulation of cardiac rhythmicity in adults characterized by a chronotropic incompetence and cardiac conduction defects, thus increasing the susceptibility to SCD. We demonstrated that Meis1 is a major regulator of sympathetic target-field innervation and that Meis1 deficient sympathetic neurons die by apoptosis from early embryonic stages to perinatal stages. In addition, we showed that Meis1 regulates the transcription of key molecules necessary for the endosomal machinery. Accordingly, the traffic of Rab5(+) endosomes is severely altered in Meis1-inactivated sympathetic neurons. These results suggest that Meis1 interacts with various trophic factors signaling pathways during postmitotic neurons differentiation.
Subject(s)
Autonomic Nervous System Diseases/genetics , Death, Sudden, Cardiac , Genetic Predisposition to Disease , Neoplasm Proteins/deficiency , Animals , Apoptosis , Autonomic Nervous System Diseases/pathology , Endosomes/metabolism , Gene Silencing , Homeodomain Proteins , Mice , Myeloid Ecotropic Viral Integration Site 1 ProteinABSTRACT
Despite the significance of transient receptor potential (TRP) channels in sensory physiology, little is known of the expression and developmental regulation of the TRPM (melastatin) subgroup in sensory neurons. In order to find out if the eight TRPM subgroup members (TRPM1-TRPM8) have a possible role in the sensory nervous system, we characterized the developmental regulation of their expression in mouse dorsal root ganglion (DRG) from embryonic (E) day 12 to adulthood. Transcripts for all channels except for TRPM1 were detected in lumbar and thoracic DRG and in nodose ganglion (NG) with distinguishable expression patterns from E12 until adult. For most channels, the expression increased from E14 to adult with the exception of TRPM5, which displayed transient high levels during embryonic and early postnatal stages. Cellular localization of TRPM8 mRNA was found only in a limited subset of very small diameter neurons distinct in size from other populations. These neurons did not bind isolectin B4 (IB4) and expressed neither the neuropeptide calcitonin gene-related peptide (CGRP) nor neurofilament (NF)200. This suggests that TRPM8(+) thermoreceptive sensory neurons fall into a separate group of very small sized neurons distinct from peptidergic and IB4(+) subtypes of sensory neurons. Our results, showing the expression and dynamic regulation of TRPM channels during development, indicate that many TRPM subfamily members could participate during nervous system development and in the adult by determining distinct physiological properties of sensory neurons.
Subject(s)
Ganglia, Spinal/embryology , Gene Expression Regulation, Developmental/physiology , Sensory Receptor Cells/metabolism , TRPM Cation Channels/metabolism , Age Factors , Animals , DNA Primers/genetics , Ganglia, Spinal/metabolism , Gene Expression Profiling , Gene Expression Regulation, Developmental/genetics , Immunohistochemistry , In Situ Hybridization , Mice , Reverse Transcriptase Polymerase Chain Reaction , Sensory Receptor Cells/physiology , TRPM Cation Channels/classificationABSTRACT
NEDD9 is a scaffolding protein in the integrin signaling pathway that is involved in cell adhesion dynamics. Little is known of the cellular localization of NEDD9 expression during embryonic development. In the present study, we have analyzed NEDD9 mRNA expression in the mouse and identified new relevant expression sites. In addition, we have characterized NEDD9 protein expression pattern for the first time in mammals. At E9.5-E10.5, high levels of Nedd9 and the neurogenic transcription factor neurogenin-2 (Ngn2) were found to largely overlap in two discrete domains of the trunk neural tube along its dorso-ventral axis, with Nedd9 extending to more ventral regions of the ventricular zone and Ngn2 differentially expressed in neuronally committed progenitors of the intermediate zone. At encephalic and trunk levels of the neural tube, NEDD9 was present in Sox2(+) progenitor cell populations mostly generating Ngn2(+) and/or Nurr1(+) cells. A sharp down-regulation of NEDD9 expression was found in cells upon lineage commitment, as observed in Nurr1(+) and Ngn2(+) mesencephalic dopaminergic and brainstem neuronal progenitors. In other tissues/organs, i.e. prospective heart, retina, olfactory epithelium, gonads, cartilage, gut and pituitary gland, NEDD9 was found to be co-expressed with Sox2, RXR alpha and/or Nurr1-like proteins, suggesting that NEDD9 expression is confined to early progenitors involved in diverse organogenesis and that it may depend on the repertoire and levels of retinoic acid co-receptors expressed by those cells.
Subject(s)
Proteins/metabolism , Stem Cells/metabolism , Adaptor Proteins, Signal Transducing , Animals , Brain Stem/cytology , Brain Stem/embryology , Brain Stem/metabolism , Cerebellum/cytology , Cerebellum/embryology , Cerebellum/metabolism , DNA-Binding Proteins/analysis , Embryo, Nonmammalian/metabolism , Gene Expression , HMGB Proteins/analysis , Mesencephalon/cytology , Mesencephalon/embryology , Mesencephalon/metabolism , Mice , Mice, Inbred C57BL , Neural Tube/cytology , Neural Tube/metabolism , Proteins/analysis , Proteins/genetics , RNA, Messenger/metabolism , SOXB1 Transcription Factors , Transcription Factors/analysisABSTRACT
Transient receptor potential (TRP) channels play essential roles in sensory physiology and their expression in different classes of sensory neurons reflect distinct receptive properties of these neurons. While expression of the TRPV, TRPA, and to a certain degree TRPM classes of channels has been studied in sensory neurons, little is known about the expression and regulation of TRPC channels. In this study we examined the regulation of all TRPC members (TRPC1-C7) throughout embryonic and postnatal development of the dorsal root ganglion (DRG) and nodose ganglion (NG). In adult mice, mRNAs for all channels were present in the DRG, with TRPC1, 3, and 6 being the most abundant, TRPC2, C4, and C5 at lower levels, and TRPC7 at very low levels. While TRPC2 mRNAs were downregulated from high levels at embryonic (E) day 12 and E14 until adult, TRPC4, C5, and C7 expressions increased from E12 to peak levels at E18. TRPC1, C3, and C6, the most abundant TRPC channel mRNAs, increased progressively from E12 to adult. Expression and regulation of TRPC channels mRNAs in the NG were unexpectedly similar to the DRG. TRPC1 and C2 was expressed in the neurofilament-200 (NF-200)-positive large size subclass of neurons, while TRPC3 mRNAs expression, which stained up to 35% of DRG neurons, was almost exclusively present in nonpeptidergic isolectin B4 (IB4)-positive small size neurons that were largely TRPV1-negative. Our results suggest important roles of the TRPC family of channels in sensory physiology of both nociceptive as well as nonnociceptive classes of neurons.
Subject(s)
Ganglia, Spinal/metabolism , Neurons, Afferent/metabolism , Nodose Ganglion/metabolism , TRPC Cation Channels/metabolism , Animals , Female , Ganglia, Spinal/cytology , Ganglia, Spinal/growth & development , Gene Expression Regulation, Developmental , Lumbar Vertebrae , Mice , Mice, Inbred C57BL , Neurons, Afferent/classification , Nodose Ganglion/cytology , Nodose Ganglion/growth & development , RNA, Messenger/analysis , TRPC Cation Channels/classification , TRPC Cation Channels/genetics , Thoracic VertebraeABSTRACT
Peripheral sensory neurons are derived from two distinct structures, the ectodermal placodes and the neural crest. Here, we establish the forkhead family transcription factor Foxs1 as an early sensory neuronal marker. Early embryonic Foxs1 expression was present in all the sensory nervous system regardless of cellular origin, but was not found in other placode and neural crest-derived cell types. Foxs1 expression was turned on in the sensory neuron precursors of the trunk. Consistently, expression of Sox10, that is present in undifferentiated multipotent neural crest cells (NCCs), was mutually exclusive to Foxs1. Acquirement of Foxs1 expression was used to study the emergence of the dorsal root ganglion (DRG) sensory neurons. Migrating pioneering Foxs1 expressing NCCs were found at the anterior dorsal somitic lip at the 18-somite stage. These cells showed limited proliferation and migrated to form a cluster in the ventral aspect of the coalescing ganglion, surrounded by Foxs1(-)/Sox10(+) migrating NCCs retaining a high rate of proliferation. Sensory neurogenesis of the Foxs1(-)/Sox10(+) precursors occurred within the condensed DRG starting with neurogenin-1 (Ngn1) and Brn3a expression. These data define a sequential emergence of neuronal precursors of the sensory nervous system with different molecular characteristics, starting during migration and continuing well after DRG condensation.
Subject(s)
Gene Expression Regulation, Developmental , Neural Crest/metabolism , Neurons, Afferent/metabolism , Transcription Factors/physiology , Animals , Female , Forkhead Transcription Factors , High Mobility Group Proteins/genetics , High Mobility Group Proteins/metabolism , In Situ Hybridization , Mice , Mice, Knockout , Neural Crest/embryology , Neurons, Afferent/cytology , Pregnancy , SOXE Transcription Factors , Transcription Factors/genetics , Transcription Factors/metabolism , beta-Galactosidase/genetics , beta-Galactosidase/metabolismABSTRACT
During the development of the nervous system, many different types of neuron are produced. As well as forming the correct type of neuron, each must also establish precise connections. Recent findings show that, because of shared gene programmes, neuronal identity is intimately linked to and coordinated with axonal behaviour. Peripheral sensory neurons provide an excellent system in which to study these interactions. This review examines how neuronal diversity is created in the PNS and describes proteins that help to direct the diversity of neuronal subtypes, cell survival, axonal growth and the establishment of central patterns of modality-specific connections.
Subject(s)
Afferent Pathways/cytology , Afferent Pathways/physiology , Cell Differentiation/physiology , Neurons, Afferent/classification , Neurons, Afferent/physiology , Animals , Cell Movement/physiology , Embryonic InductionABSTRACT
Neural crest cells (NCCs) can adopt different neuronal fates. In NCCs, neurogenin-2 promotes sensory specification but does not specify different subclasses of sensory neurons. Understanding the gene cascades that direct Trk gene activation may reveal mechanisms generating sensory diversity, because different Trks are expressed in different sensory neuron subpopulations. Here we show in chick and mouse that the Runt transcription factor Runx1 promotes axonal growth, is selectively expressed in neural crest-derived TrkA(+) sensory neurons and mediates TrkA transactivation in migratory NCCs. Inhibition of Runt activity depletes TrkA expression and leads to neuronal death. Moreover, Runx1 overexpression is incompatible with multipotency in the migratory neural crest but does not induce expression of pan-neuronal genes. Instead, Runx1-induced neuronal differentiation depends on an existing neurogenin2 proneural gene program. Our data show that Runx1 directs, in a context-dependent manner, key aspects of the establishment of the TrkA(+) nociceptive subclass of neurons.
Subject(s)
Core Binding Factor Alpha 2 Subunit/physiology , Neurons, Afferent/physiology , Nociceptors/physiology , Receptor, trkA/metabolism , Animals , Apoptosis/physiology , Cell Differentiation , Cell Survival , Cells, Cultured , Chick Embryo , Electroporation , Immunohistochemistry , In Situ Hybridization , Mice , Neural Crest/cytology , Neurons, Afferent/cytology , Nociceptors/cytology , Receptor, trkA/genetics , Transcriptional ActivationABSTRACT
Neurotrophins control neuronal survival in a target-derived manner during the period of naturally occurring cell death in development. The specificity of this mechanism has been attributed to a restricted spatio-temporal expression of neurotrophin ligands in target tissues, as well as a selective expression of their cognate tyrosine kinase (Trk) receptors in different neuronal subpopulations. However, several in vitro and in vivo studies of null mutant mice have suggested that neurotrophin 3 (NT 3) also signals through the non-preferred TrkB receptor. In this study, we have directly addressed the in vivo preference of NT 3 to signal through TrkB or TrkC, by crossing the NT 3 knock-in mice (BDNF(NT 3/NT 3) mice) with the TrkB- or TrkC-null mutant mice. We find that TrkB is dispensable, whereas TrkC is required for the neuronal rescue by the NT 3 allele in the brain-derived neurotrophic factor- and NT 3-dependent cochleovestibular system. Our results show that NT 3 maintains survival of cells as well as target innervation only through interactions with TrkC in vivo. TrkB and TrkC receptors are thus not functionally redundant for NT 3, even when coexpressed in neurons of the cochleovestibular system.
Subject(s)
Neurons/physiology , Neurotrophin 3/physiology , Receptor, trkB/physiology , Receptor, trkC/physiology , Adaptor Proteins, Signal Transducing , Animals , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Ganglia, Sensory/physiology , Immunohistochemistry , In Vitro Techniques , Merkel Cells , Mice , Mice, Mutant Strains , Neurons/metabolism , Neurotrophin 3/genetics , Polymerase Chain Reaction , Receptor, trkB/genetics , Receptor, trkB/metabolism , Receptor, trkC/genetics , Receptor, trkC/metabolism , Signal Transduction/genetics , Signal Transduction/physiologyABSTRACT
The boundary cap (BC) is a transient neural crest-derived group of cells located at the dorsal root entry zone (DREZ) that have been shown to differentiate into sensory neurons and glia in vivo. We find that when placed in culture, BC cells self-renew, show multipotency in clonal cultures and express neural crest stem cell (NCSCs) markers. Unlike sciatic nerve NCSCs, the BC-NCSC (bNCSCs) generates sensory neurons upon differentiation. The bNCSCs constitute a common source of cells for functionally diverse types of neurons, as a single bNCSC can give rise to several types of nociceptive and thermoreceptive sensory neurons. Our data suggests that BC cells comprise a source of multipotent sensory specified stem cells that persist throughout embryogenesis.
Subject(s)
Cell Differentiation/physiology , Ganglia, Spinal/embryology , Multipotent Stem Cells/cytology , Neural Crest/cytology , Neurons, Afferent/cytology , Animals , Calcium/metabolism , Cells, Cultured , DNA Primers , Fluorometry , Galactosides , Immunohistochemistry , In Situ Hybridization , Indoles , Mice , Mice, Transgenic , Multipotent Stem Cells/metabolism , Multipotent Stem Cells/physiology , Neural Crest/metabolism , Neural Crest/physiology , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Brain-derived neurotrophic factor (BDNF) is strongly expressed in the hippocampus, where it has been associated with memory processes. In the central nervous system, some learning processes, as well as brain insults, including stress, induce modifications in BDNF mRNA expression. Because stress and memory appear to share some neuronal pathways, we studied BDNF mRNA and BDNF peptide variations in response to short times of immobilization stress. Using an RNase protection assay, we demonstrated that short-time stress application induced a significant increase (at 60 min) in BDNF mRNA levels in the whole rat hippocampus. Changes in BDNF mRNA content appear to reflect increased expression of BDNF transcripts containing exons I, II, and III, that were also significantly modified at this time. The time course of stress-induced changes in BDNF transcript levels revealed that mRNA containing exon III was the first increased, significantly elevated by 15 min, attaining maximal levels at 60 min, as BDNF transcripts containing exons I and II. However, at longer times of stress (180 min), BDNF mRNA levels were decreased as well as mRNA containing exon IV. In situ hybridization analysis of discrete hippocampal layers demonstrated that BDNF mRNA expression increased as early as 15 min in most hippocampal regions, with no modification in the number of labeled cells. The same signal pattern, although less pronounced, was determined at 60 min, but at this time a significant increase in BDNF-positive cells was visualized in the CA3 layer. The peptide, measured by immunoassay, was significantly augmented after 180 min of stress exposure whereas at 300 min, levels were similar to those measured in control animals. These data suggest that rapid changes in BDNF expression may be part of a compensatory response to preserve hippocampal homeostasis or a form of neuronal plasticity to cope with new stimuli.
Subject(s)
Brain-Derived Neurotrophic Factor/genetics , Hippocampus/metabolism , Neurons/metabolism , Reaction Time/genetics , Stress, Psychological/metabolism , Up-Regulation/genetics , Animals , Brain-Derived Neurotrophic Factor/metabolism , Gene Expression Regulation/genetics , Hippocampus/cytology , Immunoassay , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Restraint, Physical/psychology , Stress, Psychological/geneticsABSTRACT
Brain derived-neurotrophic factor (BDNF) belongs to the neurotrophin family and regulates the survival, differentiation and maintenance of function in different neuronal populations. We previously reported that glutamate increases the expression of BDNF mRNA, its four transcripts and the BDNF peptide in fetal hypothalamic neurons, essentially through NMDA receptor activation. In the present study, we investigated whether GABA interacts with glutamate in the regulation of BDNF gene expression. BDNF and Trk B (BDNF receptor) mRNAs were determined by RNAse protection assay. BDNF transcripts expression levels were evaluated by semi-quantitative RT-PCR. BDNF peptide content was analyzed by enzyme immunoassay (ELISA).We found that picrotoxin (a GABA(A) receptor antagonist) stimulated BDNF mRNA expression and that GABA decreased the glutamate-induced augmentation with no effect on the expression of mRNA encoding the BDNF receptor, Trk B. Measurements of BDNF transcripts levels showed that transcripts containing exons I and III were increased by picrotoxin, whereas those containing exons II and IV were unchanged. GABA solely diminished the glutamate-stimulated expression of transcripts containing exon III. In addition, GABA also inhibited the stimulatory effect of glutamate on BDNF peptide content. Our findings show an interaction between glutamate and GABA on BDNF expression (mRNA, transcripts and peptide) in fetal hypothalamic neurons.